|
Company Contact
Scivanta Medical Corporation
215 Morris Avenue
Spring Lake, NJ 07762
| Telephone: |
732 282 1620 |
|
| Fax: |
732 282 1621 |
Contact us |
 |
 |
|
Investor Relations Contact
Tom Gifford
Executive Vice President & CFO
Telephone: 732-282-1620 x15
tgifford@scivanta.com
|
| |
|
|
Overview
Scivanta Medical Corporation (“Scivanta”) acquires and develops medical products that provide significant advantages over existing medical procedures and treatments. Scivanta has acquired exclusive worldwide rights to the Scivanta Cardiac Monitoring System, a minimally invasive esophageal catheter that provides distinct economic and patient benefits compared with existing heart monitoring devices.
Read more
|
 |
|
|
Scivanta is developing
a minimally invasive cardiac monitoring device using an esophageal balloon catheter that provides cardiac performance data similar to that obtained through pulmonary artery catheters (PACs), such as the Swan-Ganz catheter.
Read more? Click here
|
 |
|
|
|
